LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

Search

Bio-Rad Laboratories Inc

Suletud

SektorTervishoid

235.71 -0.02

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

227.98

Max

237.3

Põhinäitajad

By Trading Economics

Sissetulek

780M

64M

Müük

-82M

585M

Aktsiakasum

2.54

Kasumimarginaal

10.933

Töötajad

7,700

EBITDA

75M

134M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+32.72% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

31. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-314M

6.2B

Eelmine avamishind

235.73

Eelmine sulgemishind

235.71

Uudiste sentiment

By Acuity

50%

50%

134 / 381 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. juuni 2025, 18:52 UTC

Tulu

Accenture Shares Fall on Bookings Decline, Concerns over Federal Government Contract -- 3rd Update

22. juuni 2025, 23:59 UTC

Market Talk

Gold Edges Higher Amid Worries Over Middle East Conflict -- Market Talk

22. juuni 2025, 23:55 UTC

Market Talk

Markets Wait to See if Iran's Response Will be Symbolic or Substantial -- Market Talk

22. juuni 2025, 23:51 UTC

Market Talk

Oil Climbs After U.S. Attack on Iran's Nuclear Sites -- Market Talk

22. juuni 2025, 23:43 UTC

Market Talk

Reasons to Believe Strait of Hormuz Will Remain Open -- Market Talk

22. juuni 2025, 23:38 UTC

Market Talk

Nikkei May Fall as Middle East Uncertainty Persists -- Market Talk

22. juuni 2025, 23:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. juuni 2025, 23:11 UTC

Market Talk

Early Market Reaction to Iran Attacks Restrained -- Market Talk

22. juuni 2025, 22:59 UTC

Market Talk

Gold, Silver Rise as Investors Seek Haven After Strikes on Iran -- Market Talk

22. juuni 2025, 21:43 UTC

Market Talk

Australian Govt Says Supports US Strikes On Iran -- Market Talk

21. juuni 2025, 08:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

21. juuni 2025, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

21. juuni 2025, 08:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

20. juuni 2025, 20:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

20. juuni 2025, 20:50 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

20. juuni 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20. juuni 2025, 20:13 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Moved the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20. juuni 2025, 20:11 UTC

Market Talk

Natural Gas Slides in Late-Week Profit Taking -- Market Talk

20. juuni 2025, 19:56 UTC

Market Talk

Crude Oil Slips to End Week -- Market Talk

20. juuni 2025, 18:35 UTC

Market Talk

Warehouse Clubs Seen Growing Market Share -- Market Talk

20. juuni 2025, 18:12 UTC

Market Talk

Gold Slides to Close Shortened Week -- Market Talk

20. juuni 2025, 17:56 UTC

Market Talk

Baker Hughes Reports Slight Decrease in U.S. Rig Count -- Market Talk

20. juuni 2025, 17:50 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20. juuni 2025, 17:35 UTC

Omandamised, ülevõtmised, äriostud

Cisco Was the Dot-Com Bust's Biggest Loser. Now It's at a 25-Year High. -- Barrons.com

20. juuni 2025, 17:30 UTC

Market Talk
Tulu

Adobe's AI Headwinds Seen Fading -- Market Talk

20. juuni 2025, 17:03 UTC

Tulu

Accenture Earnings Beat Expectations. Why the Stock Is Falling Anyway. -- Barrons.com

20. juuni 2025, 16:50 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

20. juuni 2025, 16:50 UTC

Market Talk
Tulu

Accenture Seeing Companies Shift to Leapfrog Mentality -- Market Talk

20. juuni 2025, 16:44 UTC

Omandamised, ülevõtmised, äriostud

Meet QXO, the Upstart Building Materials Stock That May Battle Home Depot for GMS -- Barrons.com

20. juuni 2025, 16:40 UTC

Market Talk
Tulu

Accenture Can't Yet Estimate Longer Term Impact from Federal Cuts -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Bio-Rad Laboratories Inc Prognoos

Hinnasiht

By TipRanks

32.72% tõus

12 kuu keskmine prognoos

Keskmine 314.2 USD  32.72%

Kõrge 381 USD

Madal 245 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Bio-Rad Laboratories Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

3

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

229.835 / 235.8095Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

134 / 381 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.